Halozyme Therapeutics Income After Taxes 2010-2024 | HALO

Halozyme Therapeutics income after taxes for the twelve months ending June 30, 2024 was $0.337B, a 44.32% increase year-over-year.

  • Halozyme Therapeutics annual income after taxes for 2023 was $0.282B, a 39.31% increase from 2022.
  • Halozyme Therapeutics annual income after taxes for 2022 was $0.202B, a 49.81% decline from 2021.
  • Halozyme Therapeutics annual income after taxes for 2021 was $0.403B, a 211.97% increase from 2020.

Halozyme Therapeutics Income After Taxes 2010-2024 | HALO

  • Halozyme Therapeutics annual income after taxes for 2023 was $0.282B, a 39.31% increase from 2022.
  • Halozyme Therapeutics annual income after taxes for 2022 was $0.202B, a 49.81% decline from 2021.
  • Halozyme Therapeutics annual income after taxes for 2021 was $0.403B, a 211.97% increase from 2020.